| Wang, Dong |
NCT06704334: The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury |
|
|
| Recruiting | 4 | 50 | RoW | Median nerve electrical stimulation treatment, Huperzine A injection, Ginkgo leaf dropping pill | Wanbangde Pharmaceutical Group Co., LTD, Ganzhou City People's Hospital | Cognitive Impairment After Brain Injury | 12/26 | 12/26 | | |
| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer |
|
|
| Recruiting | 3 | 412 | RoW | fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin | Hutchmed | Advanced Endometrial Cancer | 01/29 | 06/29 | | |
NCT04060459: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer |
|
|
| Recruiting | 2 | 50 | RoW | Paclitaxel-binding albumin | Third Military Medical University | Bladder Cancer | 10/20 | 10/22 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
TQB3616-ALTN-II-01, NCT04924192: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer |
|
|
| Recruiting | 2 | 126 | RoW | TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Carcinoma | 05/23 | 12/23 | | |
NCT06421688: Effect of Vitamin C on Postoperative Pulmonary Complications After Intracranial Tumor Surgery |
|
|
| Not yet recruiting | 2 | 86 | RoW | Ascorbic acid, vitamin C, Saline, saline (medicine) | Qianfoshan Hospital | Ascorbic Acid, Neurosurgical Procedures, Humans, Ventilator-Induced Lung Injury, Postoperative Complications | 01/25 | 06/25 | | |
NCT05892237: CIETAI and Sequential Radiotherapy in Squamous Lung Cancer |
|
|
| Recruiting | 2 | 50 | RoW | bronchial artery interventional therapy, Chemotherapy drug, IMRT, Immunotherapy | Dong Wang | Carcinoma, Non-Small-Cell Lung | 02/25 | 06/26 | | |
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke |
|
|
| Recruiting | 2 | 300 | RoW | LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose | Shanghai Pharmaceuticals Holding Co., Ltd | Acute Ischemic Stroke | 04/25 | 07/25 | | |
NCT05957016: Neoadjuvant CIETAI With Concurrent Chemoradiotherapy in Local Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 90 | RoW | CIETAI-R | Third Military Medical University | Rectal Cancer | 06/25 | 06/26 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
ALT-SCLC-02, NCT04731909: Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer |
|
|
| Recruiting | N/A | 80 | RoW | Toripalimab, Toripalimab Injection, Teruipuli dankang Zhusheye, TuoYI, JS001, Anlotinib, Anlotinib Hydrochloride Capsules, FuKeWei, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection | Third Military Medical University | SCLC, Extensive Stage, Lung Cancer, Small Cell Lung Cancer | 06/22 | 06/23 | | |
NCT04471480: TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer |
|
|
| Not yet recruiting | N/A | 90 | RoW | TC/PD-1 inhibitor/anlotinib, TC/PD-1 inhibitor | Dong Wang | ESCC | 08/22 | 08/23 | | |
NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA |
|
|
| Recruiting | N/A | 492 | RoW | | LI YAN | T2DM | 12/25 | 07/26 | | |
NCT03358602: Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer |
|
|
| Not yet recruiting | N/A | 158 | RoW | Radiotherapy, Selective neck dissection | Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University General Hospital, Tianjin Medical University Second Hospital | Supraglottic Cancer | 11/25 | 11/27 | | |
NCT04989153: Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer |
|
|
| Recruiting | N/A | 5000 | RoW | pepsinogen | Second Affiliated Hospital, School of Medicine, Zhejiang University, Jilin City People's Hospital, No. 924 Hospital of the People's Liberation Army of China, Kunshan Hospital of Traditional Chinese Medicine, Chinese PLA General Hospital, Sichuan Provincial People's Hospital, Affiliated Hospital of Southwest Medical University, Zhongshan Hospital Xiamen University, Jingzhou Hospital of Traditional Chinese Medicine, Changhai Hospital | Gastric Cancer, Precancerous Lesion, Helicobacter Pylori Infection | 12/22 | 12/23 | | |
| Zhang, Xi |
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) |
|
|
| Active, not recruiting | 3 | 150 | RoW | SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone) | Antengene Corporation | Relapsed or Refractory Multiple Myeloma | 07/24 | 10/24 | | |
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS) |
|
|
| Recruiting | 3 | 552 | RoW | Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA) | TJ Biopharma Co., Ltd. | Myelodysplastic Syndromes(MDS) | 03/27 | 03/27 | | |
| Recruiting | 2/3 | 142 | RoW | avatrombopag, Doptelet, Placebo | Peking University People's Hospital, Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, Shanxi Bethune Hospital, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University | Thrombocytopenia, Stem Cell Transplant Complications | 10/24 | 10/25 | | |
NCT04684147: Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 2 | 100 | RoW | single dose of CNCT19 | Juventas Cell Therapy Ltd. | Relapsed or Refractory Acute Lymphoblastic Leukemia | 09/22 | 12/26 | | |
NCT04716686: Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma |
|
|
| Recruiting | 2 | 83 | RoW | Niraparib | Shandong University, Sun Yat-sen University, Tongji Hospital, Women's Hospital School Of Medicine Zhejiang University, Zai Lab (Shanghai) Co., Ltd. | Endometrial Carcinoma, Serous Carcinoma | 12/25 | 12/26 | | |
NCT04586478: Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma |
|
|
| Recruiting | 2 | 60 | RoW | single dose of CNCT19 | Juventas Cell Therapy Ltd. | Non-Hodgkin's Lymphoma | 12/24 | 09/25 | | |
FUMANBA-1, NCT05066646: A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma |
|
|
| Recruiting | 1/2 | 132 | RoW | CT103A | Nanjing IASO Biotherapeutics Co.,Ltd | Multiple Myeloma | 10/22 | 06/24 | | |
SWATCH, NCT05265975: A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL |
|
|
| Recruiting | 1/2 | 84 | RoW | ATG-010, Selinexor, Lenalidomide, Rituximab | Antengene Corporation | Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin Lymphoma | 03/25 | 06/25 | | |
NCT04303247: CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL |
|
|
| Not yet recruiting | 1 | 30 | RoW | CD19 and CD22 targeted CAR-T cells | Xinqiao Hospital of Chongqing, Gracell Biotechnologies (Shanghai) Co., Ltd, 920th Hospital of Joint Logistics Support Force, The Affiliated Hospital Of Guizhou Medical University, Tang-Du Hospital, The General Hospital of Western Theater Command, Chongqing University Cancer Hospital | B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent | 05/21 | 05/23 | | |
NCT04637269: Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma |
|
|
| Recruiting | 1 | 16 | RoW | anti-BCMA CAR-T | Xinqiao Hospital of Chongqing, Carbiogene Therapeutics Co. Ltd. | Multiple Myeloma | 11/21 | 11/23 | | |
NCT04638270: Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL |
|
|
| Not yet recruiting | 1 | 16 | RoW | anti-CD19 FasT CAR-T cells | Xinqiao Hospital of Chongqing, Gracell Biotechnologies (Shanghai) Co., Ltd, 920th Hospital of Joint Logistics Support Force, The Second Affiliated Hospital of Chongqing Medical University, The Affiliated Hospital Of Guizhou Medical University, The Second Affiliated Hospital of Kunming Medical University, Chongqing University Cancer Hospital | Lymphoma, Non-Hodgkin | 11/21 | 11/23 | | |
NCT04516551: Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT |
|
|
| Recruiting | 1 | 18 | RoW | anti-CD19 allo-CAR-T cells | Xinqiao Hospital of Chongqing, Gracell Biotechnologies (Shanghai) Co., Ltd, First Affiliated Hospital of Zhejiang University, The Second Affiliated Hospital of Chongqing Medical University, The Affiliated Hospital Of Guizhou Medical University, The General Hospital of Western Theater Command, Chongqing University Cancer Hospital, The First Affiliated Hospital of Anhui Medical University, Tang-Du Hospital, 920th Hospital of Joint Logistics Support ForceFirst | Relapsed Adult ALL, B Cell Leukemia | 12/21 | 12/22 | | |
NCT04639739: Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma. |
|
|
| Not yet recruiting | 1 | 9 | RoW | anti-CD19 CAR NK | Xinqiao Hospital of Chongqing, Chongqing Precision Biotech Co., Ltd | NHL | 12/21 | 12/23 | | |
NCT04264078: Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies |
|
|
| Recruiting | 1 | 30 | RoW | CD7 UCAR-T cells, Fludarabine, Cytoxan, Melphalan | Xinqiao Hospital of Chongqing, Gracell Biotechnology Shanghai Co., Ltd., 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, The Second Affiliated Hospital of Chongqing Medical University, The Affiliated Hospital Of Guizhou Medical University, Central South University, The First Affiliated Hospital of Kunming Medical College, The General Hospital of Western Theater Command, Second Affiliated Hospital of Xi'an Jiaotong University, Nanfang Hospital of Southern Medical University, Fujian Medical University Union Hospital, The First Affiliated Hospital of Anhui Medical University, Tang-Du Hospital | T-cell Leukemia, T-cell Lymphoma | 06/22 | 06/23 | | |
NCT05016063: Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Not yet recruiting | 1 | 32 | RoW | Fludarabine, Cytoxan, Dual CD33-CLL1 CAR-T cells | Xinqiao Hospital of Chongqing, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Leukemia, Myeloid, Acute | 09/22 | 09/23 | | |
NCT05008536: Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma |
|
|
| Recruiting | 1 | 27 | RoW | Anti-BCMA CAR-NK Cells, Fludarabine, Cytoxan | Xinqiao Hospital of Chongqing, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Multiple Myeloma, Refractory | 09/22 | 09/23 | | |
NCT05008575: Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1 | 27 | RoW | anti-CD33 CAR NK cells, Fludarabine, Cytoxan | Xinqiao Hospital of Chongqing, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Leukemia, Myeloid, Acute | 12/22 | 12/23 | | |
NCT05443841: Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005) |
|
|
| Recruiting | N/A | 385 | RoW | pleural lavage | Fudan University | Esophageal Cancer | 07/24 | 07/27 | | |
NCT06727669: Longitudinal Cohort of Thrombosis and Hemostasis Diseases |
|
|
| Recruiting | N/A | 3000 | RoW | | Peking University People's Hospital | Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired, Disseminated Intravascular Coagulation, Thrombophilia, Deep Vein Thrombosis, Pulmonary Embolism, Thrombotic Microangiopathies, Coagulation Factor Deficiency, Hemophilia A, Hemophilia B, Hemophilia B, Acquired, Platelet Dysfunction, Arterial Thromboembolism, Bleeding Disorder, Thrombosis | 12/29 | 12/30 | | |
| Wang, Bin S |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
ACHIEVE, NCT04808752: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases |
|
|
| Active, not recruiting | 2 | 63 | RoW | Almonertinib, Investigational Product | Zhejiang Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Lung Cancer | 06/24 | 07/24 | | |
NCT06006689: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) |
|
|
| Recruiting | 2 | 228 | RoW | Qishen Yiqi Dripping Pills placebo 3 bags, Placebo group, Low dose Qishen Yiqi Dripping Pills 3 bags, Low dose group, High dose Qishen Yiqi Dripping Pills 3 bags, High dose group | Tasly Pharmaceutical Group Co., Ltd | Diabetic Kidney Disease | 09/25 | 09/25 | | |
NCT04172168: Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI) |
|
|
| Recruiting | N/A | 17568 | RoW | Heart rupture | Xiamen Cardiovascular Hospital, Xiamen University | Acute Myocardial Infarction | 12/19 | 03/21 | | |
NCT04475978: Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients：a Prospective, Multicenter, Randomized Controlled Trial |
|
|
| Recruiting | N/A | 208 | RoW | IVUS-guide DCB PTCA, Angio-guide DCB PTCA | Xiamen Cardiovascular Hospital, Xiamen University | STEMI | 01/23 | 03/23 | | |
NCT05703191: A Real-world Study of Nitric Oxide Generator and Delivery System |
|
|
| Recruiting | N/A | 10 | RoW | Nitric Oxide Generator and Delivery System | Novlead Inc. | Pulmonary Hypertension of Newborn | 03/23 | 05/23 | | |
NCT05459714: Magnetically Controlled Capsule Endoscope System in Stomach Examination of Moderately and Severely Obese Patients |
|
|
| Not yet recruiting | N/A | 30 | RoW | MCE for obese patients | Changhai Hospital, Shanghai 6th People's Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Obesity | 05/23 | 05/23 | | |
NCT06358118: Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders |
|
|
| Not yet recruiting | N/A | 240 | RoW | Buyuan Zhixiao Formula, Placebo | Qing Ni | Diabete Mellitus, Aging, Metabolic Disorders, Traditional Chinese Medicine, Randomized Controlled Trial | 07/25 | 07/25 | | |
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort |
|
|
| Recruiting | N/A | 15000 | RoW | Treatment Strategies | Yu Bo | Acute Myocardial Infarction, Adverse Event | 08/25 | 12/26 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Recruiting | N/A | 1332 | RoW | The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours | Zhengzhou Yuan | Stroke, Acute, Endovascular Therapy | 11/25 | 04/26 | | |
| Cai, Hengzhi |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
| Qin, Zhexue |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort |
|
|
| Recruiting | N/A | 15000 | RoW | Treatment Strategies | Yu Bo | Acute Myocardial Infarction, Adverse Event | 08/25 | 12/26 | | |
